Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
The Lancet Neurology（2023）
摘要
Neurocrine Biosciences.
更多查看译文
关键词
valbenazine,huntington,chorea,treatment,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要